We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
- Authors
Lau, George K K; Piratvisuth, Teerha; Luo, Kang Xian; Marcellin, Patrick; Thongsawat, Satawat; Cooksley, Graham; Gane, Edward; Fried, Michael W; Chow, Wan Cheng; Paik, Seung Woon; Chang, Wen Yu; Berg, Thomas; Flisiak, Robert; McCloud, Philip; Pluck, Nigel; Peginterferon Alfa-2a HBeAg-Positive Chronic Hepatitis B Study Group
- Abstract
Current treatments for chronic hepatitis B are suboptimal. In the search for improved therapies, we compared the efficacy and safety of pegylated interferon alfa plus lamivudine, pegylated interferon alfa without lamivudine, and lamivudine alone for the treatment of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
- Publication
The New England journal of medicine, 2005, Vol 352, Issue 26, p2682
- ISSN
1533-4406
- Publication type
Journal Article
- DOI
10.1056/NEJMoa043470